Author Topic: Evaluation of neuromodulation in the treatment of refractory major depression  (Read 1892 times)

0 Members and 1 Guest are viewing this topic.

Sylvain Chartrand CD

  • Administrator
  • Hero Member
  • **********
  • Posts: 751
    • View Profile
Clinical Studies

Evaluation of neuromodulation in the treatment of refractory major depression

Principal investigator : Marcelo Berlim

Description of the study :

We aim to investigate the use of neuromodulation in the treatment of refractory major depression. We plan to use daily magnetic stimulation sessions to treat patients with refractory depression. To better target participants who can benefit from the use of neuromodulation tools, we wish to assess the impact of this treatment, combined with two magnetic resonance imaging scans to better target the use of neuromodulation in the treatment of refractory depression.

Financial compensations : yes

Functionning

    One daily magnetic stimulation session for 4 weeks for a total of 20 sessions. Each treatment last about 30 minutes.
    Assessments by a psychiatrist before the treatment, after the treatment and 1 month after the end of the reatment.
    2 brain scans, one before and another after the treatment, lasting about 1:30 per scan.

Benefits

    Better evaluation of the impact of neuromodulation in the treatment of depression.

Risks and discomforts

    Patients at risk for epilepsy are excluded
    Some participants can report headaches or a heating feeling on the scalp during the neuromodulation sessions

Eligibility criteria :

    Be aged 18 to 60 years
    Not have abused alcohol or illicit drugs in the past 6 months
    Not have an uncontrolled medical illness (e.g., lungs, heart, kidneys)
    Having presented, for at least two months, with symptoms associated with a depressive episode such as significant sadness, hopelessness, lack of interest,   feelings of guilt, significant problems with sleep, appetite, concentration, indecision, fatigue
    Having tried at least 1 anti-depressant during the current depression episode
    Be available for 3 interviews, for participating in a 4-week clinical trial involving daily (Monday to Friday) 40-minute sessions of neuromodulation treatment, and for 2 sessions of magnetic resonance imaging.

Information :

To participate in the study, please contact :
Maxime Pedneault
Research coordinator
Phone : 514-761-6131, ext. 3407
maxime.pedneault@douglas.mcgill.ca

http://www.douglas.qc.ca/studies/29?locale=en